Porui's precise selection of topics and expansion of growth benefits through mergers and acquisitions.

Porui Pharma has mastered the core competence of international pharmaceutical manufacturing and excels in acquiring key technologies and entering the market through mergers and acquisitions (M&A). From the past development track of acquisitions as shown in Figure 1, it is not difficult to see that Porui Pharma has launched three technology areas for positioning and market deployment, namely, small molecule chemical drugs, large molecule protein drugs, and health food products, and Porui Pharma has continued to move towards the world's top ten global contract development and manufacturing services (CDMO, CDMO) OEMs. In addition, Porui Pharma continues its internationalization by moving towards the top 10 Contract Development and Manufacturing Organization (CDMO) foundries in the world.